About This Research Study
Raised LDL cholesterol (often known as “bad cholesterol”) can lead to the buildup of fatty deposits (plaque) in your blood vessels. Over time, this can block blood vessels, making it harder for blood to flow and increasing the risk of health problems, like a heart attack, stroke or other life-threatening conditions. These conditions are called atherosclerotic cardiovascular disease (ASCVD).
Treatments like statins and other existing medicines help people manage their LDL cholesterol levels, but for some people, existing treatments do not lower LDL cholesterol levels enough and they remain at higher risk. That’s why new treatment options are needed to better support those living with raised LDL cholesterol.
Tekton Research is currently enrolling participants in a clinical trial evaluating an investigational medication intended to reduce LDL cholesterol levels. Qualified participants may be compensated up to $1,500 for time and travel.
Eligible participants…
- Must be adults 18+
- Must be diagnosed with or at risk for a first ASCVD event
- Must be on a stable dose of lipid-lowering therapies such as statins
- Will receive compensation for study-related time
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Tekton enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.